The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies

Creative Commons License

Yagci M., Suyam E., Cakar M. K.

TURKISH JOURNAL OF HEMATOLOGY, vol.32, no.3, pp.251-256, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.4274/tjh.2013.0342
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.251-256
  • Keywords: Hepatitis B, Resolved infection, Hepatitis B surface antibody, Hematological malignancy, Chemotherapy, VIRUS REACTIVATION, VIRAL-HEPATITIS, POSITIVE PATIENTS, INFECTION, RISK, MANAGEMENT, PREVENTION, LIVER
  • Gazi University Affiliated: Yes

Abstract

Objective: To investigate the influence of chemotherapy (CT) on HBsAb titer in patients receiving CT due to hematological malignancy.